title: Adverse reactions in estimation of MMR vaccination validation in Bosnian population.
abstract: BACKGROUND
  The combined MMR vaccine was introduced to induce immunity less painfully than three separate injections at the same time, and sooner and more efficiently than three injections given on different dates. MMR will protect most kids from contacting measles, mumps, or rubella throughout their lives.
  
  
  METHODS
  The vaccination status of all children was verified by reviews of their vaccination records. The outcome variables obtained from the public files of the Federal Health Public Institution Bosnia and Herzegovina between 1991 and 2007 were related to the receipt of MMR vaccine.
  
  
  RESULTS
  Adverse reactions, rarely serious, may occur from each component of the MMR vaccine. 3% of Bosnian children develop fever, malaise and a rash until three weeks after the first vaccination; only 1% develop temporary joint pain. When examining selective MMR non receipts, the family-level factors that have been traditionally associated with failure to immunize were no longer important.
  
  
  CONCLUSIONS
  Measles, mumps and rubella continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries.
  
  
  CONCLUSIONS
  The most effective way of preventing measles is the measles-mumps-rubella (MMR) vaccine and it also provides protection against two other potentially fatal childhood conditions--mumps and rubella. Vaccination is very effective in preventing and reducing the impact of serious illness. Very few children are unable to have the MMR vaccine for medical reasons.
authors.affiliation: Health center "Sarajevo", Sarajevo, Bosnia and Herzegovina.
authors.forename: Slobodan
authors.initials: S
authors.lastname: Trninic
authors.forename: Adnan
authors.initials: A
authors.lastname: Bajraktarevic
mesh_terms: D017522:Bosnia and Herzegovina; D002675:Child, Preschool; D000075202:Contraindications; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects*
chemical_list: D022542:Measles-Mumps-Rubella Vaccine